Bionsight is Other Healthcare Technology Systems in South Korea that focus on drug candidates business. Founded in 2019. They cover business area such as developer, AI-base technology platform, drug discovery, biomedical database, cut-edge deep learning model, hidden clue, enormous datum, complex network, biomedical datum, protein target, drug candidate, insight, target identification, solution, company.
Other Healthcare Technology Systems
2019
( 5 years old in 2024 )
Drug Candidates
-
09-117, WeWork Gangnam Station II
7 Teheran-ro 5-gil Gangnam-gu
Seoul, 06134
South Korea
Private
developerAI-base technology platformdrug discoverybiomedical databasecut-edge deep learning modelhidden clueenormous datumcomplex networkbiomedical datumprotein targetdrug candidateinsighttarget identificationsolutioncompany
* We use standard office opening hours in near Bionsight's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bionsight is Other Healthcare Technology Systems business from South Korea that founded in 2019 (5 years old in 2024), Bionsight business is focusing on Drug Candidates.
Bionsight headquarter office and corporate office address is located in 09-117, WeWork Gangnam Station II 7 Teheran-ro 5-gil Gangnam-gu Seoul, 06134 South Korea.
Bionsight was founded in South Korea.
In 2024, Bionsight is currently focus on drug candidates sector.
Above is snippet of Google Trends for "drug candidates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bionsight, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
